What to expect from clinical trials for metastatic cancer

A research team first reviews your diagnosis, previous treatments, test results, general health, and medicines. The trial may study a new treatment, a new combination, a different dose, or a new way to use an established treatment. A screening visit can include examinations, blood tests, scans, and questions about your medical history.

Before you decide, the team should explain the purpose, treatment plan, possible benefits, known and uncertain risks, alternatives, visit schedule, and what happens if you leave the trial. Taking part is voluntary. The study may use a comparison group, and you may not know which group you are in.

Bring a current medicine list, treatment records, scan reports if available, and a list of symptoms and priorities. Ask how often visits occur, whether travel is needed, how side effects are reported, and which practical arrangements you must plan for. Consider taking a trusted person to the consent conversation and ask for time to review the information.

During the trial, follow the visit and medicine instructions and tell the team about new symptoms, missed doses, or changes in other care. Keep written notes about symptoms, temperature if requested, and questions for the next visit.

Use the trial team’s urgent contact number for symptoms they have identified as needing prompt review. Seek emergency help for severe breathing difficulty, chest pressure, fainting, sudden confusion, uncontrolled bleeding, or rapidly worsening illness, and tell the emergency team that you are in a clinical trial.

Ask which trial fits your cancer and treatment history, what the main alternatives are, whether a comparison group is involved, how response will be assessed, and what support is available if the treatment causes side effects.